Search by Drug Name or NDC

NDC 65862-0106-30 Efavirenz 200 mg/1 Details

Efavirenz 200 mg/1

Efavirenz is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is EFAVIRENZ.

MedlinePlus Drug Summary

Efavirenz is used along with other medications to treat human immunodeficiency virus (HIV) infection. Efavirenz is in a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It works by decreasing the amount of HIV in the blood. Although efavirenz does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.

Related Packages: 65862-0106-30
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Efavirenz

Product Information

NDC	65862-0106
Product ID	65862-106_a02dd4c8-6159-48b0-a79c-c362f1f4daf9
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Efavirenz
Proprietary Name Suffix	n/a
Non-Proprietary Name	Efavirenz
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	EFAVIRENZ
Labeler Name	Aurobindo Pharma Limited
Pharmaceutical Class	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcri
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA078064
Listing Certified Through	2025-12-31

Package

NDC 65862-0106-30 (65862010630)

Pricing Information	N/A
NDC Package Code	65862-106-30
Billing NDC	65862010630
Package	30 CAPSULE in 1 BOTTLE (65862-106-30)
Marketing Start Date	2017-12-15
NDC Exclude Flag	N